Skip to main content
Scientific American
  • Cart 0
  • Forgot password?Loading
    Not yet registered?
  • |Newsletters
Advanced Search
  • COVID
  • Health
  • Mind & Brain
  • Environment
  • Technology
  • Space & Physics
  • Video
  • Podcasts
  • Opinion
  • Store
  • Subscribe
  • Current Issue
  • Cart0
  • Sign In
  • Newsletters
      Frontiers in T Cell Therapy

      Frontiers in T Cell Therapy

      CAR-T cell therapies have quickly evolved from promising idea into powerful cancer treatment, one that turns the body’s own defenses against disease. As researchers seek to extend and improve on their early successes, what can we expect next?

      • November 1, 2018
      • |
      • Photo Credit:

        Steve Gschmeissner/Science Photo Library

      Download the Report

      This report was produced for Eureka Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.

      eureka logo
      sciam logo
      The Unlikely Story of Cancer's Most Promising New Therapy
      Medical & Biotech

      The Unlikely Story of Cancer's Most Promising New Therapy

      CAR-T cell therapy uses a patient’s own cells to fight blood cancers. How a simple idea was terribly complex to realize.

      • November 1, 2018
      CAR-T 2.0: Safer, Armored, More Controlled
      Medical & Biotech

      CAR-T 2.0: Safer, Armored, More Controlled

      Three innovative spins on CAR-T cell therapy promise more benefits and reduced damage from cellular cancer treatments.

      • November 1, 2018
      The CAR-T Conundrum
      Medical & Biotech

      The CAR-T Conundrum

      For all their potential, CAR-T cell cancer therapies face significant obstacles. Bijan Nejadnik of Eureka Therapeutics explains one powerful method to overcome them.

      • November 1, 2018
      Retooling T Cell Therapies to Target Solid Tumors
      Medical & Biotech

      Retooling T Cell Therapies to Target Solid Tumors

      Cheng Liu, CEO and Chairman of Eureka Therapeutics, discusses how to beat both cancer and viral infections with treatments inspired by nature.

      November 1, 2018

      The Tell-tale Targets Hidden Inside Solid Tumors
      Medical & Biotech

      The Tell-tale Targets Hidden Inside Solid Tumors

      The next iterations of T cell therapy will go after intracellular targets that until now have been unavailable.

      November 1, 2018

      Support Science Journalism

      Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners.

      Subscribe Now!Support Science Journalism

      Follow us

      • instagram
      • soundcloud
      • youtube
      • twitter
      • facebook
      • rss

      Scientific american arabic

      العربية
      • Return & Refund Policy
      • About
      • Press Room
      • FAQs
      • Contact Us
      • Site Map
      • Advertise
      • SA Custom Media
      • Terms of Use
      • Privacy Policy
      • California Consumer Privacy Statement
      • Use of cookies/Do not sell my data
      • International Editions
      Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers.

      © 2023 Scientific American, a Division of Springer Nature America, Inc.

      All Rights Reserved.

      Scroll To Top

      Support science journalism.

      Scientific American paper issue and on tablet

      Thanks for reading Scientific American. Knowledge awaits.

      Already a subscriber? Sign in.

      Thanks for reading Scientific American. Create your free account or Sign in to continue.

      Create Account

      See Subscription Options

      Continue reading with a Scientific American subscription.

      You may cancel at any time.

      Sign in.